Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders
E. Joanna Baxter(University of Cambridge), Anthony R. Green(Wellcome/MRC Cambridge Stem Cell Institute), George S. Vassiliou(Wellcome/MRC Cambridge Stem Cell Institute), Peter J. Campbell(Wellcome Sanger Institute), Nasios Fourouclas(University of Cambridge), Linda M. Scott(University of Cambridge), Natasha Joan Curtin(Addenbrooke's Hospital), Mike Scott(Addenbrooke's Hospital), S Swanton(University of Cambridge), Clare East(Addenbrooke's Hospital), Elaine Boyd(Addenbrooke's Hospital), Anthony J. Bench(Addenbrooke's Hospital), Wendy N. Erber(The University of Western Australia)
Cited by 3,446
Related Papers
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The cancer genome
|Nature|2009|3.5k
COSMIC: exploring the world's knowledge of somatic mutations in human cancer
|Nucleic Acids Research|2014|2.4k
COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
|Nucleic Acids Research|2010|2.3k